Texas Subject | DIABETES | Introduced

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
TXHB2529Intro

Sine Die
Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.
[Detail][Text][Discuss]
2023-05-01
To House Public Health Committee
TXSB2535Intro

Sine Die
Relating to the use of prescription glucagon medication on public and private school campuses.
[Detail][Text][Discuss]
2023-03-23
To Senate Education Committee
TXHB3912Intro

Sine Die
Relating to the applicability of health benefit plan cost-sharing requirements for prescription insulin.
[Detail][Text][Discuss]
2023-03-20
To House Health Care Reform, Select Committee
Syndicate content
feedback